Completed NA INTERVENTIONAL 2-arm NCT03532945

A Follow-up Study to Evaluate the Efficacy and Safety of Novomax in Posterior Lumbar Interbody Fusion

A Long-term Follow-up Study to Evaluate the Efficacy and Safety for the Patients With Bioactive Glass-ceramic Intervertebral Spacer (Novomax) in Posterior Lumbar Interbody Fusion: Comparison With a Titanium Cage

Sponsor: BioAlpha Inc.

Conditions Degenerative Lumbar Spinal Stenosis

Interventions Bioactive Glass-Ceramic Spacer Titanium cage

Updated 4 times since 2018 Last updated: May 10, 2018 Started: Oct 28, 2010 Primary completion: Sep 13, 2013 Completion: Apr 7, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Degenerative Lumbar Spinal Stenosis, this trial is completed. The trial is conducted by BioAlpha Inc. and has accumulated 4 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BioAlpha Inc.

Data source: BioAlpha Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.